Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
4.050
-0.200 (-4.71%)
At close: Dec 5, 2025, 4:00 PM EST
4.000
-0.050 (-1.23%)
After-hours: Dec 5, 2025, 5:11 PM EST

LIXT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
2.891.044.25.354.825.07
Upgrade
Cash & Short-Term Investments
2.891.044.25.354.825.07
Upgrade
Cash Growth
76.34%-75.28%-21.48%10.98%-4.84%95.06%
Upgrade
Prepaid Expenses
0.090.110.030.060.120.08
Upgrade
Other Current Assets
2.45-0.080.150.150.08
Upgrade
Total Current Assets
5.431.154.315.565.095.23
Upgrade
Total Assets
5.431.154.315.565.095.23
Upgrade
Accounts Payable
0.120.060.120.180.190.19
Upgrade
Accrued Expenses
0.110.030.040.050.03-
Upgrade
Other Current Liabilities
0.290.240.160.170.080.03
Upgrade
Total Current Liabilities
0.520.320.310.40.30.22
Upgrade
Total Liabilities
0.520.320.310.40.30.22
Upgrade
Common Stock
000000
Upgrade
Additional Paid-In Capital
57.8949.3948.9845.0638.3731.86
Upgrade
Retained Earnings
-55.53-52.07-48.48-43.39-37.08-30.35
Upgrade
Total Common Equity
2.36-2.670.491.671.291.51
Upgrade
Shareholders' Equity
4.910.833.995.174.795.01
Upgrade
Total Liabilities & Equity
5.431.154.315.565.095.23
Upgrade
Net Cash (Debt)
2.891.044.25.354.825.07
Upgrade
Net Cash Growth
76.34%-75.28%-21.48%10.98%-4.84%95.06%
Upgrade
Net Cash Per Share
0.850.462.193.383.584.50
Upgrade
Filing Date Shares Outstanding
5.72.682.251.671.371.35
Upgrade
Total Common Shares Outstanding
5.72.252.251.661.371.24
Upgrade
Working Capital
4.910.833.995.174.795.01
Upgrade
Book Value Per Share
0.41-1.190.221.000.941.22
Upgrade
Tangible Book Value
2.36-2.670.491.671.291.51
Upgrade
Tangible Book Value Per Share
0.41-1.190.221.000.941.22
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.